Baseline (n = 94) | |
---|---|
Age (y) | 69.6 ± 8.8 |
Female (%) | 48.9 |
Height (cm) | 157.9 ± 9.3 |
Weight (kg) | 61.3 ± 11.6 |
BMI (kg/m2) | 24.5 ± 3.1 |
Current smoking habit (%) | 9.6 |
Employed (%) | 35.1 |
Symptom duration (mo) | 13.0 (6.0–46.5) |
Hypertension (%) | 48.9 |
Dyslipidemia (%) | 22.3 |
Diabetes (%) | 13.8 |
VAS score for leg numbness (mm) | 70.0 (50.0–80.0) |
Muscle weakness | |
Tibialis anterior (n, %) | 18 (19.1) |
Extensor hallucis longus (n, %) | 23 (24.5) |
Extensor digitorum longus (n, %) | 13 (13.8) |
Flexor hallucis longus (n, %) | 6 (6.4) |
Flexor digitorum longus (n, %) | 6 (6.4) |
Gastrocnemius (n, %) | 3 (3.2) |
Walking distance (m) | 200.0 (80.0–500.0) |
Surgical treatment | |
Decompression (n) | 41 |
1 level (n, %) | 27 (65.8) |
2 levels (n, %) | 10 (24.4) |
3 levels (n, %) | 4 (9.8) |
Decompression with fusion (n) | 53 |
1 level (n, %) | 28 (52.8) |
2 levels (n, %) | 24 (45.3) |
4 levels (n, %) | 1 (1.9) |